Schechter, L. E., Smith, D. L., Rosenzweig-Lipson, S., Sukoff, S. J., Dawson, L. A., Marquis, K., … Childers, W. (2005). Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties. The Journal of Pharmacology and Experimental Therapeutics, 314(3), 1274–1289. https://doi.org/10.1124/jpet.105.086363

Schechter, L. E., D. L. Smith, S. Rosenzweig-Lipson, S. J. Sukoff, L. A. Dawson, K. Marquis, D. Jones, et al. “Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties.” The Journal of Pharmacology and Experimental Therapeutics 314, no. 3 (September 2005): 1274–89. https://doi.org/10.1124/jpet.105.086363.

Schechter LE, Smith DL, Rosenzweig-Lipson S, Sukoff SJ, Dawson LA, Marquis K, et al. Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties. The Journal of Pharmacology and Experimental Therapeutics. 2005 Sep;314(3):1274–89.

Schechter, L. E., et al. “Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties.” The Journal of Pharmacology and Experimental Therapeutics, vol. 314, no. 3, Elsevier BV, Sept. 2005, pp. 1274–89. Crossref, doi:10.1124/jpet.105.086363.

Schechter LE, Smith DL, Rosenzweig-Lipson S, Sukoff SJ, Dawson LA, Marquis K, Jones D, Piesla M, Andree T, Nawoschik S, Harder JA, Womack MD, Buccafusco J, Terry AV, Hoebel B, Rada P, Kelly M, Abou-Gharbia M, Barrett JE, Childers W. Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties. The Journal of Pharmacology and Experimental Therapeutics. Elsevier BV; 2005 Sep;314(3):1274–1289.